Chromosomal translocations in human cells are generated by canonical nonhomologous end-joining
Hind Ghezraoui1, Marion Piganeau1, Benjamin Renouf1
1Museum National d'Histoire Naturelle, 43 rue Cuvier, F-75005 Paris, France; CNRS, UMR7196, 43 rue Cuvier, F-75005 Paris, France; Inserm, U1154, 43 rue Cuvier, F-75005 Paris, France.
Abstract:
Breakpoint junctions of the chromosomal translocations that occur in human cancers display hallmarks of nonhomologous end-joining (NHEJ). In mouse cells, translocations are suppressed by canonical NHEJ (c-NHEJ) components, which include DNA ligase IV (LIG4), and instead arise from alternative NHEJ (alt-NHEJ). Here we used designer nucleases (ZFNs, TALENs, and CRISPR/Cas9) to introduce DSBs on two chromosomes to study translocation joining mechanisms in human cells. Remarkably, translocations were altered in cells deficient for LIG4 or its interacting protein XRCC4. Translocation junctions had significantly longer deletions and more microhomology, indicative of alt-NHEJ. Thus, unlike mouse cells, translocations in human cells are generated by c-NHEJ. Human cancer translocations induced by paired Cas9 nicks also showed a dependence on c-NHEJ, despite having distinct joining characteristics. These results demonstrate an unexpected and striking species-specific difference for common genomic rearrangements associated with tumorigenesis.
Insights
Human cancer translocations surprisingly utilize canonical nonhomologous end-joining (c-NHEJ), unlike mouse cells. This study reveals a key species-specific difference in DNA repair mechanisms driving genomic rearrangements in cancer.
Area of Science:
- Genetics
- Molecular Biology
- Cancer Research
Background:
- Chromosomal translocations are hallmarks of human cancers.
- Nonhomologous end-joining (NHEJ) is a primary DNA repair pathway.
- Canonical NHEJ (c-NHEJ) and alternative NHEJ (alt-NHEJ) are distinct subtypes of this repair process.
Purpose of the Study:
- To investigate the mechanisms of translocation joining in human cells.
- To determine the role of canonical NHEJ (c-NHEJ) in generating chromosomal translocations.
- To compare translocation formation in human versus mouse cells.
Main Methods:
- Introduction of DNA double-strand breaks (DSBs) on two chromosomes using designer nucleases (ZFNs, TALENs, CRISPR/Cas9).
- Analysis of translocation junctions in human cells deficient for c-NHEJ components (LIG4, XRCC4).
- Assessment of translocation junction characteristics, including deletions and microhomology.
Main Results:
- Human cells deficient for LIG4 or XRCC4 exhibited altered translocations with longer deletions and more microhomology, suggesting alt-NHEJ involvement.
- Contrary to mouse models, human translocations were found to be primarily generated by c-NHEJ.
- Cancer-associated translocations induced by CRISPR/Cas9 also depended on c-NHEJ.
Conclusions:
- Human cells utilize c-NHEJ for generating chromosomal translocations, a mechanism distinct from mouse cells.
- This species-specific difference in DNA repair pathways has significant implications for understanding cancer development.
- The findings highlight the importance of considering species-specific differences in genomic rearrangement mechanisms in cancer research.
Related Concept Videos
Fixing Double-strand Breaks
Crossing Over
Crossing Over
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process...
Gene Conversion
Nondisjunction
Nondisjunction


